Oglufanide
Alternative Names: IM-862; Oglufanide disodium; ThymogenLatest Information Update: 23 Sep 2021
At a glance
- Originator Cytran
- Developer Cytran; Implicit Bioscience
- Class Antineoplastics; Dipeptides; Small molecules
- Mechanism of Action Angiogenesis inhibitors; Immunomodulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Bacterial infections; Colorectal cancer; Hepatitis C; Influenza virus infections; Kaposi's sarcoma; Ovarian cancer
Most Recent Events
- 20 Oct 2007 Preclinical trials in Bacterial infections in Australia (Intranasal)
- 27 Aug 2007 Phase-Ib clinical trials in Hepatitis C in Australia (SC)
- 27 Aug 2007 Phase-IIa clinical trials in Hepatitis C in Australia (Intranasal)